2003 Vol.21, N°6 - Suppl.32 - Table of contents

Vasculitis 2003

Guest Editors: G.S. Hoffman, L.H. Calabrese

Editorial

CER2179
2003,21,6,Suppl.32
Pg. 0001-0002

Free to view

Do we need ¹⁸F-FDG-positron emission tomography as a functional imaging technique for diagnosing large vessel arteritis?
M. Wenger, K.T. Calamia, C. Salvarani, R. Moncayo, M. Schirmer

Reviews

CER2180
2003,21,6,Suppl.32
Pg. 0003-0014

Free to view

Mass spectrometry-based proteomics and analyses of serum: A primer for the clinical investigator
V.A. Fusaro, J.H. Stone

CER2181
2003,21,6,Suppl.32
Pg. 0015-0022

Free to view

The use of (18F)Fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis
D. Blockmans

CER2182
2003,21,6,Suppl.32
Pg. 0023-0028

Free to view

Laboratory investigations useful in giant cell arteritis and Takayasu’s arteritis
C. Salvarani, F. Cantini, L. Boiardi, G.G. Hunder

CER2183
2003,21,6,Suppl.32
Pg. 0029-0034

Free to view

The role of disease-modifying antirheumatic drugs in the treatment of giant cell arteritis
D.M. Nuenninghoff, E.L. Matteson

CER2184
2003,21,6,Suppl.32
Pg. 0035-0048

Free to view

New developments in the pathogenesis of ANCA-associated vasculitis
C.J. Day, P. Hewins, C.O.S. Savage

CER2185
2003,21,6,Suppl.32
Pg. 0049-0054

Free to view

Immune phenomena in localized and generalized Wegener’s granulomatosis
A. Mueller, K. Holl-Ulrich, A.C. Feller, W.L. Gross, P. Lamprecht

CER2186
2003,21,6,Suppl.32
Pg. 0055-0063

Free to view

The role of myeloperoxidase in the pathogenesis of systemic vasculitis
A. Rutgers, P. Heeringa, J.W. Cohen Tervaert

CER2187
2003,21,6,Suppl.32
Pg. 0064-0068

Free to view

Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitis
A.P. van Rossum, P.C. Limburg, C.G.M. Kallenberg

CER2188
2003,21,6,Suppl.32
Pg. 0069-0077

Free to view

Update on the pathogenesis of Churg-Strauss syndrome
B. Hellmich, S. Ehlers, E. Csernok, W.L. Gross

CER2189
2003,21,6,Suppl.32
Pg. 0078-0084

Free to view

HCV-related cryoglobulinemic vasculitis: An update on its etiopathogenesis and therapeutic strategies
C. Ferri, D. Giuggioli, M. Cazzato, M. Sebastiani, M.T. Mascia, A.L. Zignego

CER2190
2003,21,6,Suppl.32
Pg. 0085-0088

Free to view

Cutaneous vasculitis: A diagnostic approach
M.A. Gonzalez-Gay, C. Garcia-Porrua, C. Salvarani, G. Lo Scocco, R.M. Pujol

Full Papers

CER2191
2003,21,6,Suppl.32
Pg. 0089-0094

Free to view

Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infection
P. Lamprecht, O. Gutzeit, E. Csernok, A. Gause, G. Longombardo, A.L. Zignego, W.L. Gross, C. Ferri

CER2192
2003,21,6,Suppl.32
Pg. 0095-0100

Free to view

Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies
M. Carlsson, L. Eriksson, I. Erwander, J. Wieslander, M. Segelmark

CER2193
2003,21,6,Suppl.32
Pg. 0101-0111

Free to view

Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations
D. Vassilopoulos, Z.M. Younossi, E. Hadziyannis, N. Boparai, B. Yen-Lieberman, E. Hsi, A. Villa-Forte, E. Ball, R.P. Kimberly, L.H. Calabrese

CER2194
2003,21,6,Suppl.32
Pg. 0112-0116

Free to view

Analysis of the clinical profile, autoimmune phenomena and T cell subsets (CD4 and CD8) in Takayasu’s arteritis: A hospital-based study
S.S. Uppal, S. Verma

CER2195
2003,21,6,Suppl.32
Pg. 0117-0120

Free to view

ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: Prevalence and clinical associations
H. Schultz, E. Csernok, K. Herlyn, P.H. Reichel, F. Moosig, O.A. Cornely, M.K. Fagerhol, W.L. Gross

Case Reports

CER2196
2003,21,6,Suppl.32
Pg. 0121-0123

Free to view

Visceral leishmaniasis in a patient treated for polyarteritis nodosa
P. Scatena, F. Messina, S. Gori, L. Ruocco, C. Vignali, F. Menichetti, M. Castiglioni

CER2197
2003,21,6,Suppl.32
Pg. 0124-0126

Free to view

Pulmonary artery involvement in Wegener’s granulomatosis
T. Clark, G.S. Hoffman

CER2198
2003,21,6,Suppl.32
Pg. 0127-0130

Free to view

Clinical management issues in vasculitis. Angiographically defined angiitis of the central nervous system: Diagnostic and therapeutic dilemmas
L.H. Calabrese

Clinical Vignette

CER2199
2003,21,6,Suppl.32
Pg. 0131-0132

Free to view

A headache and a mass lesion: Vasculitis or CNS sarcoid ?
L.H. Calabrese

CER2200
2003,21,6,Suppl.32
Pg. 0133-0134

Free to view

Large vessel vasculitis
C. Salvarani

CER2201
2003,21,6,Suppl.32
Pg. 0135-0137

Free to view

Four diagnostic exercises
A. Villa-Forte, G.S. Hoffman

Letter to the Editor

CER2202
2003,21,6,Suppl.32
Pg. 0138

Free to view

Successful response to infliximab in a patient with undifferentiated spondyloarthropathy coexisting with polyarteritis nodosa-like cutaneous vasculitis
C. Garcia-Porrua, M.A. Gonzalez-Gay

Review of the recent literature

CER2203
2003,21,6,Suppl.32
Pg. 0139

Free to view

Highlights from the literature 2002-2003: The Editorial Board
G.S. Hoffman, C.G.M. Kallenberg, C. Salvarani, J.H. Stone